Back to Feed
STAT+: The old Vinay Prasad never left. He just changed jobs

This is the online version of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. Drug reviews are a frustratingly opaque process, so absent subpoena power, one cannot fully discount the possibility...

🔗 Read more: https://www.statnews.com/2026/02/12/prasad-takes-conservative-approach-rare-disease-drugs-adams-biotech-scorecard/?utm_campaign=rss

#News #Medicine #Biology #Biotech #Tech #Software #Science
Edited

Comments

No comments yet. Be the first to comment!